Clinical Trials Logo

Rectal Tumors clinical trials

View clinical trials related to Rectal Tumors.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03573791 Recruiting - Rectal Cancer Clinical Trials

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

Start date: May 21, 2018
Phase:
Study type: Observational

Neoadjuvant therapy has been widely applied to locally advanced rectal cancer. However, about 50% of patients receiving this therapy do not respond well as evidenced by the fact that their T or N stages are not effectively decreased judged by postoperative pathological examination. The purpose of this trail is to identify the biomarkers (from within patients' tumor mass before neoadjuvant therapy) to predict resistance to neoadjuvant therapy. These biomarkers can help stratify neoadjuvant-resistant patients towards surgery while avoiding unnecessary chemoradio-based neoadjuvant therapy.

NCT ID: NCT03074461 Recruiting - Rectal Cancer Clinical Trials

Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial

CSAR
Start date: April 5, 2017
Phase: N/A
Study type: Interventional

CSAR Trial's aim is to determine whether the transverse coloplasty pouch or the side-to-end anastomosis as rectal reservoir reconstruction offers the best functional results.